2020
DOI: 10.1186/s12884-020-03216-z
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of maternal functioning during pregnancy and postpartum: findings from the cross-sectional WHO pilot study in Jamaica, Kenya, and Malawi

Abstract: Background The World Health Organization’s definition of maternal morbidity refers to “a negative impact on the woman’s wellbeing and/or functioning”. Many studies have documented the, mostly negative, effects of maternal ill-health on functioning. Although conceptually important, measurement of functioning remains underdeveloped, and the best way to measure functioning in pregnant and postpartum populations is unknown. Methods A cross-sectional study among women presenting for antenatal (N = 750) and postpa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 36 publications
1
10
0
Order By: Relevance
“…Our finding is consistent with previous studies showing women with a clinically diagnosed direct and indirect maternal morbidity were generally more likely to have a lower level of functioning compared with those with no condition. 11 18 Another study from Malaysia also showed that women who experienced severe morbidity had lower overall functional ability at 1 month postpartum compared with women without severe morbidity and that the difference between the two groups had disappeared by 6 months postpartum, although most women had not achieved full functional status by this time. 13 …”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…Our finding is consistent with previous studies showing women with a clinically diagnosed direct and indirect maternal morbidity were generally more likely to have a lower level of functioning compared with those with no condition. 11 18 Another study from Malaysia also showed that women who experienced severe morbidity had lower overall functional ability at 1 month postpartum compared with women without severe morbidity and that the difference between the two groups had disappeared by 6 months postpartum, although most women had not achieved full functional status by this time. 13 …”
Section: Discussionmentioning
confidence: 96%
“…Calculation of the sample size was done by comparing two proportions using Epi-Info software V.7. Accordingly, a minimum sample size of 753 (251 exposed and 502 non-exposed) was calculated by taking 0.05 α, power of 90%, 1.96 OR, 15.4% of mothers with indirect maternal morbidity having least well-functioning quintile (20% of women in the fifth quantile against the first four quantiles of WHODAS total score) as defined by a previous article, 11 1:2 ratio of exposed to non-exposed and by adding 10% non-response rate. 11 Based on the number of delivering mothers who visited each hospital during the previous 1 year (annual report of each hospital), proportional allocation of the total sample size was carried out to attain the required sample size in each hospital.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…One comparable study included women from Malawi, Kenya, and Jamaica and reported 18% of women had poor function at six weeks postpartum [22]. It is important to note that that study used different tools to measure functionality and focused on di culties in performing activities, while our study considered functional status as a multifaceted measure of mobility, level of energy, selfcare, performance of usual activities, and overall health.…”
Section: Discussionmentioning
confidence: 98%
“…The GHQ-12 has been used extensively to assess psychiatric morbidity in low-and middle-income countries, including Kenya, where it has been validated and used in previous randomized controlled trials, including that by Bryant et al on PM+ (Abubakar and Fischer 2012;Getanda, Papadopoulos, and Evans 2015;Bryant et al 2017). The PSS and WVS items have also been previously validated and used in Kenya (Haushofer and Shapiro 2016;Haushofer et al 2020), and the same is true for the WHODAS (Bryant et al 2017;Cresswell et al 2020). The scales had good properties in our sample, with Cronbach's alpha values of 0.88 for GHQ-12, 0.60 for PSS, and 0.78 for WHODAS.…”
Section: Id2 Variablesmentioning
confidence: 99%